Business Description
Metro Healthcare Bhd
ISIN : MYQ0329OO001
Compare
Compare
Traded in other countries / regions
03005.Malaysia IPO Date
2018-02-26Description
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.67 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 1.13 | |||||
| Interest Coverage | 13.04 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 7.75 | |||||
| Beneish M-Score | -3.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.6 | |||||
| 3-Year EBITDA Growth Rate | 12.3 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 44.2 | |||||
| 3-Year Book Growth Rate | 17.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.29 | |||||
| 9-Day RSI | 9.29 | |||||
| 14-Day RSI | 8.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.96 | |||||
| Quick Ratio | 2.58 | |||||
| Cash Ratio | 2 | |||||
| Days Inventory | 25.71 | |||||
| Days Sales Outstanding | 11.08 | |||||
| Days Payable | 37.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.4 | |||||
| Dividend Payout Ratio | 0.63 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 2.4 | |||||
| 5-Year Yield-on-Cost % | 15.12 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.66 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.98 | |||||
| Operating Margin % | 20.08 | |||||
| Net Margin % | 13.75 | |||||
| FCF Margin % | 14.44 | |||||
| ROE % | 18.19 | |||||
| ROA % | 11.27 | |||||
| ROIC % | 16.02 | |||||
| ROC (Joel Greenblatt) % | 26.21 | |||||
| ROCE % | 19.03 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.5 | |||||
| Forward PE Ratio | 0.21 | |||||
| PE Ratio without NRI | 27.5 | |||||
| Price-to-Owner-Earnings | 27.5 | |||||
| PEG Ratio | 0.8 | |||||
| PS Ratio | 3.79 | |||||
| PB Ratio | 5 | |||||
| Price-to-Tangible-Book | 5.38 | |||||
| Price-to-Free-Cash-Flow | 24.44 | |||||
| Price-to-Operating-Cash-Flow | 15.71 | |||||
| EV-to-EBIT | 21.53 | |||||
| EV-to-EBITDA | 14.23 | |||||
| EV-to-Forward-EBITDA | 12.08 | |||||
| EV-to-Revenue | 4.52 | |||||
| EV-to-Forward-Revenue | 3.9 | |||||
| EV-to-FCF | 31.99 | |||||
| Price-to-Projected-FCF | 2.15 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
| Price-to-Graham-Number | 2.39 | |||||
| Earnings Yield (Greenblatt) % | 4.64 | |||||
| FCF Yield % | 3.25 | |||||
| Forward Rate of Return (Yacktman) % | 23.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Metro Healthcare Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 47.468 | ||
| EPS (TTM) (RM) | 0.008 | ||
| Beta | 0.43 | ||
| Volatility % | 4.97 | ||
| 14-Day RSI | 8.32 | ||
| 14-Day ATR (RM) | 0.015035 | ||
| 20-Day SMA (RM) | 0.340625 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (RM) | 0.215 - 0.4725 | ||
| Shares Outstanding (Mil) | 978.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Metro Healthcare Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Metro Healthcare Bhd Stock Events
| Event | Date | Price(RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Metro Healthcare Bhd Frequently Asked Questions
What is Metro Healthcare Bhd(XKLS:0329)'s stock price today?
The current price of XKLS:0329 is RM0.22. The 52 week high of XKLS:0329 is RM0.47 and 52 week low is RM0.22.
When is next earnings date of Metro Healthcare Bhd(XKLS:0329)?
The next earnings date of Metro Healthcare Bhd(XKLS:0329) is .
Does Metro Healthcare Bhd(XKLS:0329) pay dividends? If so, how much?
The Dividend Yield %  of Metro Healthcare Bhd(XKLS:0329) is 2.4% (As of Today), Highest Dividend Payout Ratio of Metro Healthcare Bhd(XKLS:0329) was 1.67. The lowest was 0.12. And the median was 0.45. The  Forward Dividend Yield % of Metro Healthcare Bhd(XKLS:0329) is 2.4%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers